The White River High boys will head to the state wrestling championships on a serious high note, having won last week’s district title and qualified a whopping 15 wrestlers to the Class 3A state meet.
Hutchinson High School announced its honor rolls for the first trimester of the 2022-23 school year. The GPA requirements for the honor rolls are 3.0-3.49 for the B honor roll, 3.5-3.89 for cum ...
(Oldenburg, IN) – Oldenburg Academy teacher Helen Yane has been awarded the Lilly Teacher Creativity Fellowship. According to the Lilly Endowment, this competitive program “enables educators to pursue ...
PHILADELPHIA (AP) — Kino Lilly Jr. scored 34 points and made eight 3-pointers ... Aaron Cooley had 10 points and shot 4 of 11 from the field, including 1 for 4 from 3-point range, and went 1 for 3 ...
(Oldenburg, Ind.) - Oldenburg Academy teacher Helen Yane has been awarded the Lilly Teacher Creativity Fellowship. According to the Lilly Endowment, this competitive program “enables educators to ...
If obesity is a chronic disease, like kidney or heart conditions, demand for GLP-1 drugs shouldn’t ebb and flow with the seasons. But the weight-loss market is far from typical. After analyzing ...
With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.
For Hoosiers seeking a fresh start or a pathway to a fulfilling career, the Lilly Scholars ... manufacturing field. “This is a wonderful partnership between Eli Lilly and Company and Ivy Tech ...
Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...
Trump said on Monday that he would consider making Saudi Arabia his first foreign trip as president again ... s most highly valued company and Eli Lilly the biggest pharma group in the world.
As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has approved Novo Nordisk’s semaglutide for heart disease and Eli Lilly’s ...
Eli Lilly's Q4 FY24 guidance adjustment is due to supply chain factors, not demand, creating an attractive buying opportunity with a 'Buy' rating. Despite a modest 0.6% revenue reduction ...